|
Personal History
EDUCATION1997: Howard University, Washington D.C., Bachelor of Science in Mathematics
2002: University of Pennsylvania School of Medicine, Philadelphia, PA, Master of Science in Cellular and Molecular Biology
2003: University of Pennsylvania School of Medicine, Philadelphia, PA, Doctor of Medicine
2008: University North Carolina, Chapel Hill, NC, Master of Public Health in Biostatistics
POST GRADUATE EDUCATION AND TRAINING
2003-2004: Pediatric Internship, Duke University Medical Center
2004-2006: Pediatric Residency, Duke University Medical Center
2006-2008: Clinical Research Fellowship, Duke Clinical Research Institute
2006-2010: Pediatric Cardiology Fellowship, Duke University
Research Interests
Pediatric Hypertension and Congenital Heart DiseaseClinical Speciality
General Pediatric CardiologyPublications
Baker-Smith CM, Neish SR, Klitzner TS, Beekman RH, Kugler JD, Martin GR, Lannon C, Jenkins KJ, Rosenthal GL. Variation in Post-Operative Care following Stage I Palliation for Single Ventricle Patients: A Report from the JCCHD National Quality Improvement Collaborative. Congenit Heart Dis. 2011 Mar-Apr;6(2):116-27.Baker-Smith CM, Benjamin DK, Califf RM, Murphy MD, Li JS, Smith PB. Cough in Pediatric Patients Receiving Angiotensin Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Therapy in Randomized Controlled Trials. Clinical Pharmacology Therapeutics. 2010 Jun; 87(6):668-71.
Baker-Smith CM, Milazzo AM, Frush DP, Jaggers J, Kirby ML, Kanter RJ, Barker PC. Case Report: Double Aortic Arch with Aortic Atresia and Left-Sided Type B Interruption. Congenital Heart Disease. 2010 May-Jun; 5(3):316-20.
Baker-Smith CM, Benjamin DK, Grabowski HG, Reid ED, Mangum B, Goldsmith JV, Murphy MD, Edwards R, Eisenstein EL, Sun J, Califf RM, Li JS. The Economic Returns of Pediatric Clinical Trials of Anti-Hypertensive Drugs. Am Heart J. 2008; 156(4):682-8.
Benjamin DK, Smith PB, Jadhav P, Gobburu JV, Murphy DM, Hasselblad V, Baker-Smith CM, Califf RM, Li JS. Pediatric Antihypertensive Trial Failures: Analysis of End Points and Dose Range. Hypertension. 2008; 51(4): 834-840.
Li JS, Baker-Smith C, Smith PB, Hasselblad V, Murphy DM, Califf RM, Benjamin DK. Racial Difference in Blood Pressure Response to Angiotensin-Converting Enzyme Inhibitors in Children: A Meta-Analysis. Clinical Pharmacology Therapeutics. 2008; 84(3):315-9.
Zhang GX, Baker CM, Kolson DL, Rostami AM. Review: Chemokines and chemokine receptors in the pathogenesis of multiple sclerosis. Multiple Sclerosis. 2000; 6(1):3-13.
Faculty members:
Update your contact information and create a profile.